2353. Multidrug-Resistant MRSA: No Options?
Session: Interactive Session: Difficult to Treat Gram-Positives: A Case-Based Symposium
Saturday, October 29, 2016: 2:00 PM
Room: La Nouvelle Orleans Ballroom
Arnold Bayer, MD, FIDSA, David Geffen School of Medicine at UCLA and LA Biomedical Research Institute At Harbor, Los Angeles, CA; Medicine-Infectious Diseases, LABiomed Research Institute at Harbor-UCLA Medical Center, Torrance, CA


Disclosures:

A. Bayer, Cubist Pharmaceuticals: Grant Investigator , Grant recipient and Research grant
Theravance Pharmaceuticals: Grant Investigator , Grant recipient and Research grant
ContraFect Corp: Consultant and Grant Investigator , Research grant

Previous Presentation | Next Presentation >>

Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.